Innovation Norway invites Norwegian companies to join us at BIO-Europe 2024 and take the opportunity to expand their business internationally. As Europe’s premier life science partnering event, BIO-Europe offers unparalleled access to global industry leaders, potential partners, and key decision-makers.
Key Benefits:
- Expand Your Network: Engage with over 5,500 industry professionals from more than 60 countries.
- Partnership Opportunities: Connect with 2,800 companies looking to collaborate and innovate.
- Insightful Program: Learn from 30 years of successful partnerships and envision the future of life sciences.
What to Expect at BIO-Europe 2024?
The BIO-Europe program is designed to address the latest trends, challenges and opportunities in life science. Hear from industry experts as their share the insights that could inspire your next business move.
Collaborate to Innovate:
- Business of Biotech: Learn about the importance and benefits of collaboration and sustainability as we take a journey through the past and future 30 years of innovation in the industry.
- Therapeutic Insights: Engage with industry leaders, innovators, CMDOs, and patient advocates to discover insights, strategic collaborations, and emerging opportunities that shape the future and foster a collaborative environment for groundbreaking advancements and partnerships.
- Ecosystem Innovation: Explore innovative life science ecosystems, both locally and globally. Hear case studies about the successes and pitfalls of regional developments and learn from companies as they share novel solutions for unmet needs.
Don’t miss this opportunity to engage with key players in the health and life science industry and elevate your business on the global stage. If you are interested in attending, please contact us to discuss how you can take part in this event.
Organisers
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.